This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Telomir Pharmaceuticals receives FDA IND clearance for Telomir-Zn to treat triple-negative breast cancer, enabling Phase 1/2 clinical trials. #Biotech #Cancer
2026-05-15T03:41:19.173Z